Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer

M Sasako, S Sakuramoto, H Katai… - Journal of clinical …, 2011 - ascopubs.org
Purpose The first planned interim analysis (median follow-up, 3 years) of the Adjuvant
Chemotherapy Trial of S-1 for Gastric Cancer confirmed that the oral fluoropyrimidine …
被引用次数：1518 相关文章
[PDF] academia.edu

[PDF][PDF] Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

M Sasako, S Sakuramoto, H Katai, T Kinoshita… - 2011 - academia.edu
Purpose The first planned interim analysis (median follow-up, 3 years) of the Adjuvant
Chemotherapy Trial of S-1 for Gastric Cancer confirmed that the oral fluoropyrimidine …
[PDF] cinj.org

[PDF][PDF] Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

M Sasako, S Sakuramoto, H Katai, T Kinoshita… - J Clin Oncol, 2011 - cinj.org
Purpose The first planned interim analysis (median follow-up, 3 years) of the Adjuvant
Chemotherapy Trial of S-1 for Gastric Cancer confirmed that the oral fluoropyrimidine …

Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer

M Sasako, S Sakuramoto, H Katai… - Journal of clinical …, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose The first planned interim analysis (median follow-up, 3 years) of the Adjuvant
Chemotherapy Trial of S-1 for Gastric Cancer confirmed that the oral fluoropyrimidine …

Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer.

M Sasako, S Sakuramoto, H Katai… - Journal of Clinical …, 2011 - europepmc.org
Purpose The first planned interim analysis (median follow-up, 3 years) of the Adjuvant
Chemotherapy Trial of S-1 for Gastric Cancer confirmed that the oral fluoropyrimidine …
[PDF] archive.org

[PDF][PDF] Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

M Sasako, S Sakuramoto, H Katai, T Kinoshita… - J Clin …, 2011 - scholar.archive.org
Purpose The first planned interim analysis (median follow-up, 3 years) of the Adjuvant
Chemotherapy Trial of S-1 for Gastric Cancer confirmed that the oral fluoropyrimidine …
[PDF] researchgate.net

[PDF][PDF] Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

M Sasako, S Sakuramoto, H Katai, T Kinoshita… - 2011 - researchgate.net
Purpose The first planned interim analysis (median follow-up, 3 years) of the Adjuvant
Chemotherapy Trial of S-1 for Gastric Cancer confirmed that the oral fluoropyrimidine …

[引用][C] Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

M SASAKO, S SAKURAMOTO, H KATAI… - Journal of clinical …, 2011 - pascal-francis.inist.fr
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1
Versus Surgery Alone in Stage II or III Gastric Cancer CNRS Inist Pascal-Francis CNRS Pascal and …
[PDF] cinj.org

[PDF][PDF] Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

M Sasako, S Sakuramoto, H Katai, T Kinoshita… - J Clin Oncol, 2011 - cinj.org
Purpose The first planned interim analysis (median follow-up, 3 years) of the Adjuvant
Chemotherapy Trial of S-1 for Gastric Cancer confirmed that the oral fluoropyrimidine …

Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

M Sasako, S Sakuramoto, H Katai, T Kinoshita… - Journal of Clinical …, 2011 - cir.nii.ac.jp
< jats: sec>< jats: title> Purpose</jats: title>< jats: p> The first planned interim analysis
(median follow-up, 3 years) of the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer …